Artemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Emergent Medicinal Therapeutics
Hayward will advise on capital formation and investor relationships as Artemis deepens its institutional reach, with the firm managing more than $300 million.
- On Wednesday, Sept. 23, 2026, Artemis Growth Partners announced the appointment of James Hayward as Advisory Director, following his 35-year career at JPMorgan building the firm's European credit distribution franchise.
- Hayward previously founded and led JPMorgan's European hedge fund credit business, navigating multiple market cycles as the global medicinal therapeutics market enters a more mature phase of development.
- At Artemis, Hayward will advise on capital formation, strategic financing, and Limited Partner relationships while working alongside co-founder and Chief Investment Officer William Muecke and Managing Partner E. Stanton McLean, his former JPMorgan partner.
- Managing more than $300 million in discretionary assets, Artemis applies its Five Pillars of Impact framework across North America and Europe, combining capital-markets expertise with understanding of scientific and regulatory environments.
- Investors are placing greater emphasis on governance as regulatory frameworks evolve. Hayward stated, "Most institutional investors remain unaware of how rapidly the industry is developing," signaling significant opportunity for sophisticated capital.
36 Articles
36 Articles
Artemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Emergent Medicinal Therapeutics
LONDON, Sept. 23, 2026 /PRNewswire/ -- Artemis Growth Partners ("Artemis"), a global investment firm specializing in regulated medical cannabis and emergent medicinal therapeutics, today announced the appointment of James Hayward as Advisory Director.
Artemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Em
LONDON, Sept. 23, 2026 /PRNewswire/ -- Artemis Growth Partners ("Artemis"), a global investment firm specializing in regulated medical cannabis and emergent medicinal therapeutics, today announced the
Artemis Growth Partners Names James Hayward Advisory Director
LONDON -- Artemis Growth Partners, a global investment firm specializing in regulated medical cannabis and emergent medicinal therapeutics, appointed James Hayward as advisory director. Hayward joins Artemis following a 35-year career at JPMorgan, where he founded and led JPMorgan's European hedge fund credit
Coverage Details
Bias Distribution
- 61% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
